Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
Markets & Stocks · page 4
- Markets & Stocks
Cannabis Stocks Today — Thursday 7 May 2026: Curaleaf Leads +9.4% as Sector Rallies
BoC Cannabis Index +1.67% on broad strength; Curaleaf +9.4% leads a 27-stock advance, IIPR -4.3% the day’s worst.
- Markets & Stocks
Cannabis Stocks Today — Wednesday 6 May 2026: Innovative Industrial Properties Leads +14.03% as Sector Rallies
BoC Cannabis Index gains +1.26% as Innovative Industrial Properties surges +14.03%, lifting US MSOs and ETFs in a synchronised cannabis rally.
- M&A Activity
Curaleaf Completes Full Acquisition of Germany’s Four 20 Pharma
Curaleaf Holdings has completed the buyout of the remaining 45% stake in Four 20 Pharma GmbH, making the Paderborn-based medical cannabis producer and distributor a wholly owned subsidiary of the international cannabis giant.
- Markets & Stocks
Cannabis Stocks Today — Thursday 30 April 2026: Ayr Wellness Leads +30.7% as Sector Rallies
Cannabis stocks closed broadly higher Thursday with the BoC Cannabis Index up 2.65%, every ETF gaining at least 3.9%, and Ayr Wellness pacing the universe at +30.7% even as several US MSOs lagged the rally.
- Interviews
‘Thoughtful, Prudent, Patient’ – Why Village Farms Is Sitting Out the M&A Rush
The M&A scramble for Europe has continued at a fearsome pace over the last few weeks.
- Markets & Stocks
Cannabis Stocks Today — Wednesday 29 April 2026: Sector Slides as MAPS Falls 12.9%
The BoC Cannabis Index fell roughly 3.3% on Wednesday with 32 of 39 tracked stocks closing lower; Trulieve led gainers (+7.0%) while WM Technology slumped 12.9%.
- Markets & Stocks
Cannabis Stocks Today — Tuesday 28 April 2026: Cresco Labs Leads +19% as US MSOs Rally
BoC Cannabis Index edges +0.34% as US multi-state operators rally led by Cresco Labs +19%, while cannabis ETFs and Canadian LPs slide.
- M&A Activity
Has Rescheduling Accelerated the Cannabis M&A Wave?
Last week’s rescheduling announcement has placed a spotlight firmly on the medical cannabis arms of North America’s largest operators.
- Investment & Finance
The Fight for Cannabis Rescheduling Is Far From Over
Last week’s rescheduling announcement came as a surprise to many, not least to us here at Business of Cannabis.
- Investment & Finance
Federal Agencies Reportedly Told to Prep for Imminent Cannabis Rescheduling Announcement
Cannabis stocks have once again been sent flying in the wake of the latest hint of progress on cannabis rescheduling from Trump’s White House.
- Public Markets
Green Shoots: Spring 2026 Brings Integration, Recovery, and New Supply Chains to Global Cannabis
The second quarter of 2026 has brought tentative signs of stabilisation to a cannabis sector that spent much of 2025 fighting for survival.
- CBD Market
CBD Enters US Healthcare Through Medicare Pilot, But Coverage Remains Limited
US Medicare patients have now been given access to cannabidiol (CBD) products through a landmark federal pilot scheme, helping boost cannabis stocks.
